BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 36905356)

  • 21. Potent and Targeted Activation of Latent HIV-1 Using the CRISPR/dCas9 Activator Complex.
    Saayman SM; Lazar DC; Scott TA; Hart JR; Takahashi M; Burnett JC; Planelles V; Morris KV; Weinberg MS
    Mol Ther; 2016 Mar; 24(3):488-98. PubMed ID: 26581162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repurposing CRISPR System for Transcriptional Activation.
    Chen M; Qi LS
    Adv Exp Med Biol; 2017; 983():147-157. PubMed ID: 28639197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcriptional reprogramming in yeast using dCas9 and combinatorial gRNA strategies.
    Jensen ED; Ferreira R; Jakočiūnas T; Arsovska D; Zhang J; Ding L; Smith JD; David F; Nielsen J; Jensen MK; Keasling JD
    Microb Cell Fact; 2017 Mar; 16(1):46. PubMed ID: 28298224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase-separated DropCRISPRa platform for efficient gene activation in mammalian cells and mice.
    Ma S; Liao K; Li M; Wang X; Lv J; Zhang X; Huang H; Li L; Huang T; Guo X; Lin Y; Rong Z
    Nucleic Acids Res; 2023 Jun; 51(10):5271-5284. PubMed ID: 37094074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small-Molecule-Mediated Split-Aptamer Assembly for Inducible CRISPR-dCas9 Transcription Activation.
    Liu XH; Li BR; Ying ZM; Tang LJ; Wang F; Jiang JH
    ACS Chem Biol; 2022 Jul; 17(7):1769-1777. PubMed ID: 35700146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiplexed Transcriptional Activation or Repression in Plants Using CRISPR-dCas9-Based Systems.
    Lowder LG; Paul JW; Qi Y
    Methods Mol Biol; 2017; 1629():167-184. PubMed ID: 28623586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CRISPR-Act2.0: An Improved Multiplexed System for Plant Transcriptional Activation.
    Malzahn A; Zhang Y; Qi Y
    Methods Mol Biol; 2019; 1917():83-93. PubMed ID: 30610630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CRISPR/dCas9 platforms in plants: strategies and applications beyond genome editing.
    Moradpour M; Abdulah SNA
    Plant Biotechnol J; 2020 Jan; 18(1):32-44. PubMed ID: 31392820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CRISPRa-Mediated Upregulation of
    Weuring WJ; Dilevska I; Hoekman J; van de Vondervoort J; Koetsier M; van 't Slot RH; Braun KPJ; Koeleman BPC
    CRISPR J; 2021 Aug; 4(4):575-582. PubMed ID: 34406040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CRISPR/dCas9-Based Systems: Mechanisms and Applications in Plant Sciences.
    Karlson CKS; Mohd-Noor SN; Nolte N; Tan BC
    Plants (Basel); 2021 Sep; 10(10):. PubMed ID: 34685863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A review on CRISPR/Cas-based epigenetic regulation in plants.
    Jogam P; Sandhya D; Alok A; Peddaboina V; Allini VR; Zhang B
    Int J Biol Macromol; 2022 Oct; 219():1261-1271. PubMed ID: 36057300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CRISPR/dCas system as the modulator of gene expression.
    Kazi TA; Biswas SR
    Prog Mol Biol Transl Sci; 2021; 178():99-122. PubMed ID: 33685602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted CRISPR activation is functional in engineered human pluripotent stem cells but undergoes silencing after differentiation into cardiomyocytes and endothelium.
    Karbassi E; Padgett R; Bertero A; Reinecke H; Klaiman JM; Yang X; Hauschka SD; Murry CE
    Cell Mol Life Sci; 2024 Feb; 81(1):95. PubMed ID: 38372898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CRISPR/dCas9 for hepatic fibrosis therapy: implications and challenges.
    Luo N; Zhong W; Li J; Lu J; Dong R
    Mol Biol Rep; 2022 Dec; 49(12):11403-11408. PubMed ID: 35960410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene activation by a CRISPR-assisted
    Xu X; Gao J; Dai W; Wang D; Wu J; Wang J
    Elife; 2019 Apr; 8():. PubMed ID: 30973327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A programmable hierarchical-responsive nanoCRISPR elicits robust activation of endogenous target to treat cancer.
    Liu C; Wang N; Luo R; Li L; Yang W; Wang X; Shen M; Wu Q; Gong C
    Theranostics; 2021; 11(20):9833-9846. PubMed ID: 34815789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RNA-guided transcriptional regulation in planta via synthetic dCas9-based transcription factors.
    Piatek A; Ali Z; Baazim H; Li L; Abulfaraj A; Al-Shareef S; Aouida M; Mahfouz MM
    Plant Biotechnol J; 2015 May; 13(4):578-89. PubMed ID: 25400128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RNA-guided transcriptional activation via CRISPR/dCas9 mimics overexpression phenotypes in Arabidopsis.
    Park JJ; Dempewolf E; Zhang W; Wang ZY
    PLoS One; 2017; 12(6):e0179410. PubMed ID: 28622347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulating Gene Expression in Epstein-Barr Virus (EBV)-Positive B Cell Lines with CRISPRa and CRISPRi.
    Wang LW; Trudeau SJ; Wang C; Gerdt C; Jiang S; Zhao B; Gewurz BE
    Curr Protoc Mol Biol; 2018 Jan; 121():31.13.1-31.13.18. PubMed ID: 29337370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergistic Upregulation of Target Genes by TET1 and VP64 in the dCas9-SunTag Platform.
    Morita S; Horii T; Kimura M; Hatada I
    Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32106616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.